Outlook on the Transfection Technologies Global Market to 2026 – by Product Type, Application, Transfection Method, Technology, End-user and Region

DUBLIN, Sept. 3, 2021 /PRNewswire/ — The «Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026″…

DUBLIN, Sept. 3, 2021 /PRNewswire/ — The «Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026» report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The global transfection technologies market is expected to reach a value of US$ 1.5 Billion by 2026, exhibiting a CAGR of 8.44% during 2021-2026. Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.



The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.



Key Questions Answered in This Report:

  • How has the global transfection technologies market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the transfection technologies market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the transfection method?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transfection technologies market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:



1 Preface



2 Scope and Methodology



3 Executive Summary



4 Introduction

4.1 Overview

4.2 Key Industry Trends



5 Global Transfection Technologies Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast



6 Market Breakup by Product Type

6.1 Reagent

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Instrument

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Others

6.3.1 Market Trends

6.3.2 Market Forecast



7 Market Breakup by Application

7.1 Therapeutic Delivery

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Bio-Medical Research

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Protein Production

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Others

7.4.1 Market Trends

7.4.2 Market Forecast



8 Market Breakup by Transfection Method

8.1 Lipofection

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Eletroporation

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Nucleofection

8.3.1 Market Trends

8.3.2 Market Forecast

8.4 Cotransfection

8.4.1 Market Trends

8.4.2 Market Forecast

8.5 Cationic Lipid Transfection

8.5.1 Market Trends

8.5.2 Market Forecast

8.6 In-Vivo Transfection

8.6.1 Market Trends

8.6.2 Market Forecast

8.7 Others

8.7.1 Market Trends

8.7.2 Market Forecast



9 Market Breakup by Technology

9.1 Physical Transfection

9.1.1 Market Trends

9.1.2 Market Forecast

9.2 Biochemical Based Transfection

9.2.1 Market Trends

9.2.2 Market Forecast

9.3 Viral-Vector Based Transfection

9.3.1 Market Trends

9.3.2 Market Forecast



10 Market Breakup by End-User

10.1 Research Centers and Academic Institutes

10.1.1 Market Trends

10.1.2 Market Forecast

10.2 Hospitals and Clinics

10.2.1 Market Trends

10.2.2 Market Forecast

10.3 Pharmaceutical and Biotechnology Companies

10.3.1 Market Trends

10.3.2 Market Forecast

10.4 Others

10.4.1 Market Trends

10.4.2 Market Forecast



11 Market Breakup by Region

11.1 North America

11.1.1 United States

11.1.1.1 Market Trends

11.1.1.2 Market Forecast

11.1.2 Canada

11.1.2.1 Market Trends

11.1.2.2 Market Forecast

11.2 Asia Pacific

11.2.1 China

11.2.1.1 Market Trends

11.2.1.2 Market Forecast

11.2.2 Japan

11.2.2.1 Market Trends

11.2.2.2 Market Forecast

11.2.3 India

11.2.3.1 Market Trends

11.2.3.2 Market Forecast

11.2.4 South Korea

11.2.4.1 Market Trends

11.2.4.2 Market Forecast

11.2.5 Australia

11.2.5.1 Market Trends

11.2.5.2 Market Forecast

11.2.6 Indonesia

11.2.6.1 Market Trends

11.2.6.2 Market Forecast

11.2.7 Others

11.2.7.1 Market Trends

11.2.7.2 Market Forecast

11.3 Europe

11.3.1 Germany

11.3.1.1 Market Trends

11.3.1.2 Market Forecast

11.3.2 France

11.3.2.1 Market Trends

11.3.2.2 Market Forecast

11.3.3 United Kingdom

11.3.3.1 Market Trends

11.3.3.2 Market Forecast

11.3.4 Italy

11.3.4.1 Market Trends

11.3.4.2 Market Forecast

11.3.5 Spain

11.3.5.1 Market Trends

11.3.5.2 Market Forecast

11.3.6 Russia

11.3.6.1 Market Trends

11.3.6.2 Market Forecast

11.3.7 Others

11.3.7.1 Market Trends

11.3.7.2 Market Forecast

11.4 Latin America

11.4.1 Brazil

11.4.1.1 Market Trends

11.4.1.2 Market Forecast

11.4.2 Mexico

11.4.2.1 Market Trends

11.4.2.2 Market Forecast

11.4.3 Others

11.4.3.1 Market Trends

11.4.3.2 Market Forecast

11.5 Middle East and Africa

11.5.1 Market Trends

11.5.2 Market Breakup by Country

11.5.3 Market Forecast



12 SWOT Analysis



13 Value Chain Analysis



14 Porters Five Forces Analysis



15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

15.3.1 Agilent Technologies Inc.

15.3.1.1 Company Overview

15.3.1.2 Product Portfolio

15.3.1.3 Financials

15.3.1.4 SWOT Analysis

15.3.2 Bio-RAD Laboratories Inc.

15.3.2.1 Company Overview

15.3.2.2 Product Portfolio

15.3.2.3 Financials

15.3.2.4 SWOT Analysis

15.3.3 Lonza Group AG

15.3.3.1 Company Overview

15.3.3.2 Product Portfolio

15.3.3.3 Financials

15.3.3.4 SWOT Analysis

15.3.4 Maxcyte Inc.

15.3.4.1 Company Overview

15.3.4.2 Product Portfolio

15.3.3.3 Financials

15.3.5 Mirus Bio LLC

15.3.5.1 Company Overview

15.3.5.2 Product Portfolio

15.3.6 Polyplus Transfection

15.3.6.1 Company Overview

15.3.6.2 Product Portfolio

15.3.7 Promega Corporation

15.3.7.1 Company Overview

15.3.7.2 Product Portfolio

15.3.8 Roche Holding AG

15.3.8.1 Company Overview

15.3.8.2 Product Portfolio

15.3.8.3 Financials

15.3.9 Sigma-Aldrich Corporation

15.3.9.1 Company Overview

15.3.9.2 Product Portfolio

15.3.10 Thermo Fisher Scientific Inc.

15.3.10.1 Company Overview

15.3.10.2 Product Portfolio

15.3.10.3 Financials

15.3.10.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/haxkil

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com   



For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



U.S. Fax: 646-607-1904

Fax (outside U.S.): +353-1-481-1716

Cision View original content:https://www.prnewswire.com/news-releases/outlook-on-the-transfection-technologies-global-market-to-2026—by-product-type-application-transfection-method-technology-end-user-and-region-301369087.html

SOURCE Research and Markets